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Summary A monoclonal antibody was prepared against DIDS, an inhibitor of anion transport, and used to
compare the occurrence and distribution of DIDS-binding sites of tumorigenic and non-tumorigenic human
somatic-cell hybrids. The monoclonal antibody (E8) was produced by the fusion of the mouse myeloma (NS-
1) with mouse spleen cells and is of the IgGI subclass. The apparent half-saturation of DIDS for HEp-2 cells
is 16yM and the reaction is rapid. The number of binding sites on tumorigenic and non-tumorigenic hybrid
cells was the same. The DIDS-binding protein occurs homogeneously on all cells, a characteristic which
distinguishes it from the possible tumour antigen recognised by the M/27 monoclonal antibody.
The work reported herein is the result of a search
for the identity of the 4,4'-diisothiocyano-2,2'-
disulphonic stilbene-binding protein (DIDS-BP) of
the cell membrane of non-erythroid cells. This
search originated from the observation that DIDS
could modify the binding of a monoclonal antibody
(M/27) which recognises a membrane protein
associated with glucose transport (Gingrich et al.,
1981a, b; Banyard et al., 1982) which may be the
Bramwell-Harris glycoprotein specific for
tumorigenic cells (Bramwell & Harris, 1978). Thus
it is important to know if, and how, the DIDS-
binding protein is related to the glucose transport
protein and the 105Mr Bramwell-Harris glyco-
protein.
In addition to these empirical reasons for wishing
to know more about the DIDS-binding proteins of
non-erythroid cells, there is reason to think that the
removal of lactate and the buffering of intracellular
protons by HCOQ transported from extracellular
fluid ought to assume particular importance in
malignant cells. The maintenance of intracellular
pH depends, essentially, on three pathways: (i) the
Na+/H+ (amiloride-sensitive) exchanger, (ii) the
inorganic anion transporter and (iii) the organic
anion transporter (Pace & Travin, 1983). It might
be expected that anion-transport would be rapid in
malignant cells because the high rate of glycolysis,
which is characteristic of malignant cells, will result
in the production of large amounts of lactic acid
(Vaupel et al., 1981). If a drop of intracellular pH
is to be avoided, exchange of Cl-/HCOQ, Na+/H+
and the efflux of lactate must be rapid (Roos &
Boron, 1981). In addition anion transport may be
an important modulator of cell growth and
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proliferation. It has recently been shown
(L'Allemain et al., 1984) that if the HCOQ is
removed from the growth medium of Chinese
hamster lung fibroblasts then blockade of the
Na+/H+ exchanger with amiloride prevents serum-
stimulated initiation of growth. Since DIDS
specifically inhibits the flux of inorganic anions at
micromolar concentration (Cabantchik &
Rothstein, 1974; Deuticke et al., 1982) and at
higher concentrations can also block lactate
transport (Jennings & Adams-Lackey, 1982) it was
chosen as the most appropriate probe to investigate
the structure and regulation of the anion
transporter of normal and malignant cells.
This paper describes the preparation of a
monoclonal antibody (E8) against DIDS and
describes the application of this antibody to study
the amount and heterogeneity of expression of the
DIDS-binding proteins of normal and tumorigenic
human cells. This information is used to compare
and contrast the DIDS-binding protein with the
M/27 antigen.
Materials and methods
Cell culture
Cells were maintained in Dulbecco's Modified
Eagle Medium (Gibco, No. 430-2100) in an
incubator maintained at 5% (v/v) CO2 in air at
37°C. The medium was supplemented with either
10% (v/v) foetal calf serum (FCS) or 5% foetal calf
serum and 5% (v/v) newborn calf serum (NCS)
together with 1 mM L-glutamine, 20mM sodium
pyruvate, 50Iuml -1 penicillin G, 50Iuml -1 strepto-
mycin sulphate and 80Iuml-1 neomycin sulphate.
The cultures were checked at regular intervals for
mycoplasma by the method of Chen (1977). Cells
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to be harvested for the analysis of DIDS-binding
proteins were detached from the glass bottles
with 7mMNa2HPO4-2H20, 3mMNaH2PO4-2H20,
137mMNaCl (PBS) containing 0.02% (w/v)
EDTA. A suspension culture of HeLa cells was
grown in Minimal Essential Medium modified for
suspension culture (S-MEM, Gibco No. 410-1800).
pH was maintained with 5% (v/v) CO2 in air and
25mMNaHCO3. The medium was supplemented as
described above using 5% (v/v) FCS/5% (v/v)
NCS.
Conjugation ofDIDS to proteins
DIDS (Pierce Chemical Company, No. 20047) was
covalently attached to proteins and unbound DIDS
removed by dialysis. The protein solutions were
prepared at 1-10mgml-1 in PBS and DIDS was
added to a 10-100 molar excess. The solution was
mixed for 1.5-4 h at 20°C, in the dark, and the
reaction continued overnight at 4°C. The solution
was then extensively dialyzed against PBS and
stored at -20°C. Proteins used were: bovine serum
albumin, BSA (Sigma No. A7638), ovalbumin
(Sigma No. A5503), human gammaglobulin, HGG
(Sigma No. G2011) and carbonic anhydrase, CA
(Sigma No. C7500).
Preparation ofmonoclonal anti-DIDS antibodies
Female BALB/c mice were initially immunized
subcutaneously with 50,ug DIDS-HGG in Freund's
complete adjuvant. The immunization was repeated
3 times over 3 months and a final intraperitoneal
injection of 200,pg of the antigen was given 4 days
before removing the spleen for fusion. The non-
secreting myeloma NS-1 was used for fusion and
standard techniques were followed (Kohler &
Milstein, 1975).
Solid-phase radioimmunoassay
The presence of antibodies against DIDS was
measured by radio-immunoassay of culture
supernatants on Immunolon 2 Removawell strips
(Dynatech Laboratories, No. 011-010-6302) which
were coated with a DIDS-ovalbumin conjugate at
lSjigml - in PBS for 1 h at 37°C. BSA (5%, w/v)
was used to block the remaining binding sites.
Primary and secondary antibodies were incubated
in the well for 1 h each and free antibody removed
by washing with PBS. Ovalbumin was used as a
negative control.
In experiments to demonstrate the specificity of
E8 for DIDS (Figure 1), the protein solutions were
absorbed to the wells at 100jgml-1 in PBS for 1 h
at 37°C and blocked with BSA, as before, but
thereafter additional washing steps were used.
Following the BSA-blocking the wells were washed
with 25mMTris/HClpH 7.4, 140mM NaCl (TBS)
for 5min then with TBS containing 0.05% (v/v)
Triton x 100 for 10min and finally washed in TBS
again for 5min. Fiftyjl of the primary antibody
solution at 25gml-1 in TBS/1% FCS was applied
per well. Unbound primary antibody was removed,
after 1 h incubation at 20°C, by washing as before
(2min each step). ['251]-rabbit antimouse antibody
(RAM) was added at 2.6x 104cpm per 50,u1 in
TBS/1% FCS. After a further 1h incubation the
wash procedure was repeated (5, 10, 5min) and the
dry wells counted.
The binding ofDIDS to the cell membrane
The concentration of DIDS necessary to saturate
the high affinity binding sites was determined by a
saturation-binding assay. Increasing concentrations
of freshly prepared DIDS were added to
4 x 106HEp-2 cells suspended in Sml of PBS. The
reaction proceeded in the dark for 10min at 4°C
with frequent mixing. The reaction was stopped by
adding an equal volume of TBS containing
5mM 1,2-diamino ethane (Fluka, K3596-/25/2/4).
The cells were pelleted at 400g for 3 min and
resuspended in Sml of TBS. The cells were pelleted
again and resuspended to 2 x 107 cellsml-1 in PBS.
The amount of DIDS bound to the cell membrane
was determined by saturation-binding assay.
Saturation- and Trace-binding assays
The basic method of Letarte-Muirhead et al., (1975) was followed. One hundredjil of E8 culture
supernantant or 50jil of purified E8 at 25mgml-
was used for the primary antibody incubation. The
[1251]labelled rabbit anti-mouse IgG (H+L) (Miles No. 65.157) was used at 25jgml-1 or higher. Cells
were resuspended to 2 x 107Mml- in PBS and 50pi
was used per well. Determinations were made in
triplicate or quadruplicate.
Flow cytometry
HeLa spinner cells were washed 4 x in PBS and
DIDS conjugated to the membrane as described
previously. Two hundred and fifty,ul of cells at
2x 107cellsml-1 were resuspended in saturating
amounts of ascites (M/27) or purified antibody (E8) prepared in TBS/l % FCS/0.02% NaN3. (TBS/FCS/Az). Following an incubation of I h, the
cells were washed with TBS/FCS/Az and incubated
with 1:40 dilution of FITC labelled RAM (Dako, No. F232) for a further hour. The cells were
washed 3 times and resuspended to 1 ml in PBS for
analysis on the FACS (Beckton Dickinson, FACS
IV). The cells were maintained at 4°C until the time
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Results
Characterization ofthe monoclonal antibody
The specificity of the E8 monoclonal antibody was
determined by comparing the binding of E8 to four
different proteins to which DIDS had or had not
been conjugated. DIDS was mixed at 100:1 molar
ratio (DIDS:protein) to samples of ovalbumin,
bovine serum albumin, human gamma globulin and
carbonic anhydrase as described in materials and
methods. Another monoclonal antibody, JCS-2,
was used as a negative control. JCS-2 is an IgG2a
monoclonal anti-glycophorin (unpublished results).
In all cases the binding of E8 to the unconjugated
proteins was similar to the binding of the negative
control and significantly lower than the binding of
E8 to the DIDS-conjugated proteins (Figure 1).
Hence, within the scope of the comparison E8 is
specific for DIDS. The epitope or immuno-
dominant region of DIDS is unknown but E8 is
not absorbed by any of a panel of sulphated
compounds including chondroitin 4-sulphate,
heparin, fucoidon and carrageenan.
The E8 monoclonal antibody was shown to be of
the IgGl isotype by double diffusion against
monospecific commercial antisera (data not shown).
Ovalbumin Bovine
serum
albumin
Human Carbonic
gamma anhydrase
globulin
Figure 1 The specificity of binding of E8 monoclonal
antibody for DIDS. Five Mg of protein (±DIDS) were
added per well to plastic microtitre dishes and the
binding of E8, (El) and JCS-2, (0) was measured by
solid-phase radioimmunoassay. The bars represent 1
s.d. The assay was performed in quadruplicate.
The kinetics ofbinding ofDIDSfor the cell
membrane
The rate of binding of DIDS to HeLa cells
followed biphasic kinetics, a rapid initial phase,
which was completed in 5-10min, was followed by
a phase with a slower rate which did not reach
saturation during the 60min of the time-course
studied. A separate experiment of the kinetics of
the 0-10min period conflrmed the rapid initial
binding of DIDS (unpublished observations). The
biphasic rate of binding observed in these
experiments is very similar to the binding of H2
DIDS to the erythrocyte membrane at 20°C (Lepke
et al., 1976, Figure 3).
A measure of the affinity of binding of DIDS for
its receptor was examined in HEp-2 cells (a human
laryngeal carcinoma cell line). A concentration-
dependent saturation was reached at 50-100M with
half-saturation at 16 M (Figure 2). These experi-
ments measure only the rapid phase of binding
since the reaction was terminated at 10min. The
value of 16yM is intermediate between the Ki of
DIDS for the inorganic anion transporter of the
human erythrocyte, (Cabantchik & Rothstein, 1974;
Lepke et al., 1976) and the Ki of DIDS for the
organic anion transporter which Jennings &
Adams-Lackay (1982) found to be inhibited by 80%
at IOO1 M H2 DIDS. It is reasonable to expect that
non-erythroid cells have transporters for both
inorganic and organic anions (Spencer & Lehringer,
1976) but no systematic comparisons are available
in the literature to suggest the relative abundance of
each.
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Figure 2 The kinetics of binding of DIDS to the cell
membrane. An increasing concetration of DIDS was
added to a constant number of HEp2 cells at 4°C for
10min and the resulting amount of DIDS bound to
the membrane was measured by a saturation-binding
assay. Insert: Time-course of binding of 100,uM DIDS
to HeLa cells at 4°C. The bars represent 1 s.d. Each
point was determined in triplicate.
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A comparison ofthe expression ofDIDS-binding
protein on normal and tumorigenic cells.
A number of different cell types were conjugated
with DIDS (at saturation) and the amount of
DIDS bound 10%6 cells was measured by the
saturation-binding assay. Initial experiments
showed that HEp-2 had significantly (P<I0i0l)
more DIDS-binding sites than the non-tumorigenic
MRC-5 (a human foetal fibroblast) cells. A more
stringent comparison was then made. The number
of DIDS-binding sites was compared on a series of
hybrids between D98/AH-2 (a HeLa variant
deficient in HGPRT) and normal human fibroblasts
(Stanbridge et al., 1982). No difference was found
in the number of DIDS-binding sites between the
tumorigenic variants (SE and 39E) and those in
which tumorigenicity had been suppressed (5L and
ESH) and (Figure 3).
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Figure 3 A compairson of the number of DIDS-
binding sites on normal, malignant and hybrid cell
lines. The bar represents one standard deviation.
Tumorigenic cell lines unmarked; non-tumorigenic cell
lines cross-hatched. Each point was determined in
quadruplicate.
A comparison ofthe expression ofthe DIDS-binding
protein and the M/27 determinant
Previous experiments with M/27 monoclonal
antibody have demonstrated the antigen to be
expressed heterogeneously; a small proportion of
the cell population is labelled much more heavily
than the bulk of the population (Gingrich et al.,
1981b; Banyard & White, 1984). The cells heavily
labelled with M/27 monoclonal antibody have two
features in common, they are in S-phase of the cell
cycle (Gingrich et al., 1981b) and they transport
glucose more rapidly than the cell population as a
whole (Banyard & White, 1984). Because the
binding of DIDS to the cell-surface increases the
number of M/27 binding sites it was suggested that
the DIDS-binding protein and the M/27 antigen
must either be the same, or be clearly associated in
the cell membrane (Banyard et al., 1982). But since
the binding of DIDS does not compete with M/27
(Banyard et al., 1982) the binding sites cannot be
identical nor within the molecular radii of M/27
plus DIDS. They could occur at distant sites on the
same molecule; in which case binding of DIDS
could exert an allosteric effect at a distant site of
the same molecule which facilitates the binding of
M/27 to its epitope.
The fluorescence activated cell sorter (FACS) was
used to distinguish between the two possibilities (i)
that the binding sites occur on the same molecule,
in which case their expression should be co-
regulated or (ii) that the binding sites occur on
different molecules so that non-coordinate
regulation might occur. The heterogeneity of
binding of M/27 is recognised on the FACS as a
skewing of the fluorescence distribution to the
right. If all cells within the population bind the
monoclonal equally, a single peak, which follows a
Poisson distribution, should be recorded. Figure 4
shows E8 labels a single peak of cells
homogeneously whereas the cells labelled with M/27
antibody demonstrate a skewed distribution of
more fluorescent cells. The proportion of cells in
the skewed tail (more fluorescent than channel 59)
is -20% of the total cells counted, a figure in
agreement with previous work (Gingrich et al.,
1981b; Banyard & White, 1984). The absolute
number depends, of course, on the arbitrary point
of cut-off which was, in this instance, taken as the
point of divergence between the E8 and the M/27
profile (Figure 4). The value of 20% in the skewed
tail was determined by subtracting the percent of
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Figure 4 A FACS analysis of the fluorescence
heterogeneity, A, and size heterogeneity, B, of HeLa
spinner cells conjugated with 100lpM DIDS and
labelled with either E8 monoclonal antibody, profile 1,
or M/27 monoclonal antibody, profile 2. Both profiles
were aligned so the peaks (determined by the
instrument) coincided to channel 31/32. The skewing is
illustrated by the arrow.
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cells greater than channel 59 for E8 from the
percent greater than channel 59 for M/27. These
results suggest that the DIDS-binding is not
coordinately expressed with the M/27 determinant
and is therefore presumably on a separate molecule.
The dissimilar number of binding sites for M/27
and E8 on HeLa spinner cells support this
conclusion. HeLa spinner cells have nearly 4 times
more DIDS-sites than M/27 binding sites (Table I).
Table 1 A comparison of the number of DIDS- and
M/27-binding sites on HeLa cells.
Antibody bound
Antibody (CMP/106 cells) Number Significance
M/27 60,676+6284 4
E8a 237,428+25616 4 P<0.001
aDIDS was bound to cells at 100,uM, for 10min and a
saturation binding assay done to determine the amount of
antibody bound. Specific activity of ['251]-RAM was
4.5 x 105cpmpg1. Results are expressed +s.d.
Discussion
The concentration at which DIDS half-saturates
HEp-2 cells was found to be 16,M, a value which
is intermediate between the Ki of DIDS for the
inorganic anion transporter (Band 3) of the human
erythrocyte, which is about 1 uM (Cabantchik &
Rothstein, 1974; Lepke et al., 1976) and the Ki of
DIDS for the organic anion transporter which
Jennings & Adams-Lackey (1982) found to be
inhibited by 80% at 10pMH2 DIDS. It should be
noted that the DIDS and H2 DIDS have slightly
different requirements for binding to their
substrates (Lepke et al., 1976) but both effectively
inhibit inorganic anion transport. The apparently
simple kinetics of binding over 5-10min suggests a
single major binding site but the use of an indirect-
antibody assay to determine this point in detail is
inappropriate because of the complex kinetics
which characterise the antigen-antibody reaction.
Since the apparent Ki is intermediate between the
inorganic and the organic anion transporter no
rational guess can be made about which one is the
major DIDS-binding protein of malignant cells but
the molecules appear to be structurally distinct. The
lactate transporter of the rabbit erythrocyte
membrane labelled by [3H]H2-DIDS has a relative
molecular mass (Mr) on SDS-PAGE of 4.3 x 104
(Jennings & Adams-Lackey, 1982) whereas the
inorganic anion transporter has a relative molecular
mass of 9.5 x 104 (Cabantchik & Rothstein, 1974).
The data comparing the number of DIDS-
binding sites on tumorigenic and non-tumorigenic
cells suggests that the Vma, for lactate and inorganic
anions is not rate-limiting in tumorigenic cells. This
finding supports the work of Johnson et al., (1980)
which shows that lactate transport had to be almost
completely blocked before intracellular pH fell.
Spencer & Lehninger (1976) also found that the
maximal rate of lactate transport was far in excess
of the production of lactate by glycolysis in Ehrlich
ascites tumour cells.
Three independent pieces of information suggest
that the DIDS-binding protein and the M/27
antigen are different molecules. Firstly, the DIDS-
binding protein, measured indirectly with the E8
monoclonal antibody, is expressed homogeneously
on all cells within the population whereas M/27 is
not. Secondly, DIDS does not compete with M/27
but in fact enhances binding of M/27 (Banyard et
al., 1982). This observation suggests that when the
DIDS-binding protein and M/27 antigen coexist in
the same cell there is a close topological association
between them. The importance of such membrane
complexes is supported by the observation that
DIDS and ouabain both independently cause an
alteration of the NMR-resonance of [31P]-2,3-
diphosphoglycerate through the membrane (Fossel
& Solomon, 1983) suggesting that long-range
allosteric effects may operate between apparently
unrelated membrane molecules. Finally, the
dissimilar levels of expression of E8 and M/27 on
the same cell also supports the idea that the
proteins are distinct entities. A direct comparison of
the number of sites per cell should not however be
overinterpreted since the stoichiometry of [1251]-
RAM binding to an IgM monoclonal antibody
(M/27) and to a IgG1 monoclonal antibody (E8) is
likely to be different. Furthermore since the M/27
determinant is heterogenously expressed the number
of sites per cell can only be expressed as an
arithmetic mean of the binding to the whole
population.
The possible topological assocation between the
M/27 antigen and the DIDS-binding protein is
currently being studied directly by the purification
of the DIDS-binding component. Previous,
extensive attempts to purify the M/27 determinant
in quantity have been unsuccessful. It is hoped that
this new approach will finally resolve the
relationship between the DIDS-binding protein and
the Bramwell-Harris 1 x 105Mr glycoprotein (Bramwell & Harris, 1978).
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